Blue Horseshoe Stocks: Bottom-Plays & More

Big Board Bottom Plays

Ra Pharmaceuticals, Inc. RARX – The first of a pair of NASDAQ-listed stocks with nice chart setups, RARX has actually been building a solid recovery trend off of its bottom since last week. A couple of Form-4 filings around the same time show two huge $15M blocks purchase by two separate insiders at the stock’s lows.

Meanwhile, there’s still a fair bit of ground to recover from what it has lost in the past ten weeks or so. RARX flirted with its 50DMA yesterday, so we’ll be looking for a break past that point, with indicators on the chart suggesting a fair chance of that happening.


Liberty Tax, Inc. TAX – We’ve also noted the recent bludgeoning of TAX, which has been in a general downtrend for the better part of five months. In this case, we haven’t reached bottom-bouncer status yet, but more of a bottom-watch. At present, the stock is now heavily oversold, on the heels of the dismissal of its CEO.

With tax season upon us, this is the time of year that we’d expect companies such as TAX to do their highest volume of business, so now seems as good a time as any to track this play for a bottom-bounce.

Advance Auto Parts, Inc. AAP

The last time we talked about AAP was a few months back, and we managed to find some nice gain opportunities within the AAP options chain following the company’s strong quarterly report.

AAP reported quarterly earnings once again this morning, and we thought we’d take another crack at it, by signaling the AAP 03/16 $105-115 Calls for observation.

Extended Watchlist:

Blue Horseshoe Stocks: SPY Recap & More

SPDR S&P 500 ETF (SPY) – Recap

Our primary focus in Friday morning’s premarket report was the SPY, for which we had signaled and tracked a range of calls the previous day. Our initial targets were the SPY Weekly $270-272 Calls. and Friday we expanded that range to include the SPY Weekly $272.50-274 Calls.

After another bullish session for the SPY on Friday, we’ve got updates to the highs and overall possible gains on our original contracts, as well as the maximum intraday profits that could have been seized with our rolled up strike prices. All in all, we ended up with two incredible sets of one and two-day runners without a single dud in the bunch!

$270 Calls – Range: .85-5.32 – Max Gain: 526%
$270.50 Calls – Range: .70-4.69 – Max Gain: 570%
$271 Calls – Range: .52-4.33 – Max Gain: 733%
$271.50 Calls – Range: .39-3.80 – Max Gain: 874%
$272 Calls – Range: .30-3.31 – Max Gain: 1003%

$272.50 Calls – Range: .60-2.84 – Max Gain: 373%
$273 Calls – Range: .55-2.36 – Max Gain: 329%
$273.50 Calls – Range: .43-1.89 – Max Gain: 339%
$274 Calls – Range: .17-1.42 – Max Gain: 735%

DropCar Inc. DCAR

Catching our eye as a potential bottom-bounceplay this morning is DCAR, which, prior to today, has already begun to come up off of recently registered lows on Friday. As you can see on the included chart, our favorite indicators are clearly pointing up, with a MACD cross underway and a rapidly strengthening RSI.

This morning, a new catalyst has entered into the mix, with the company reporting a new agreement with Jaguar/Land Rover Manhattan. The dealership will use DropCar’s Enterprise Vehicle Assistance & Logistics technology platform to automate the pickup and delivery of customer vehicles for service and maintenance.

Despite gapping up moderately in the premarket, is still a fair bit of unrealized upside potential, so we’ll add DCAR to our radars and keep a close watch over it in coming sessions.

Extended Watchlist:

Incoming search terms:

  • 1AHF
  • D1J9

Blue Horseshoe Stocks: Potential Bottom-Plays & More

Potential Rebound Plays

U.S. Stem Cell, Inc. USRM  -We caught USRM for some nice gain opportunities a couple of weeks back. We had initially begun tracking this play after mentioning it on the morning of February 27th. Subsequent to that, we had witnessed an impressive run from a low of .014  to .0545, for a 289% gain in a span of just two sessions.

That was followed by an expected period of consolidation, but it appears as if USRM has found support at .0175. We’re going to want to return to monitoring this play more closely on the chance that it could be gearing up for another run. If it produced a move even a fraction of what we saw before, it will be worth its slot on our watchscreens.


Iconic Brands, Inc. ICNB – Speaking of familiar plays that could be in line for a rebound in upcoming sessions, we want to swing back around to ICNB this week. We had tracked this one to some decent gains after tagging it for observation on January 24th. Following that, the stock would trade in a range from .018 up to .0339, a respectable move of 88%

But like the above-mentioned stock, after its run, it basically underwent a big-time consolidation which lasted nearly a whole month. That brings us up to yesterday, when we noticed ICNB giving off something of a rebound signal. We’ll go back to watching more closely in the next few sessions.

Aralez Pharmaceuticals, Inc. ARLZ – Bottom Watcher

ARLZ has been falling off a cliff this week, and despite the fact that it may yet have further to fall, we’re going to want to begin monitoring it as it attempts to sniff out a solid support level. There could definitely be some opportunities waiting for traders that can properly time the recovery.

Direxion Daily Jr Gld Mnrs Bull 3X ETF  (JNUG) – Reminder

Apart from some quick chances for early gains yesterday, our freshly formulated options idea for JNUG may need some time to mature. That’s why we chose an expiration date a couple of weeks out. We’ll continue to have the JNUG 03/31 $7-8 Calls on our radars moving forward.

Extended Watchlist: